(Q81343161)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17891057%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

title

Preferable use of intravitreal bevacizumab as a pretreatment of vitrectomy for severe proliferative diabetic retinopathy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17891057%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

1 reference

1 reference

proliferative diabetic retinopathy

1 reference

K Ishikawa

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17891057%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

S Honda

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17891057%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Y Tsukahara

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17891057%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

A Negi

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17891057%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

publication date

21 September 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17891057%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17891057%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

volume

23

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17891057%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17891057%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

page(s)

108-111

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17891057%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/sj.eye.6702983

8 January 2020

exact match

0 references

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6702983

7 January 2021

Benefits and limitations in vitreoretinal surgery for proliferative diabetic retinopathy and macular edema

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6702983

7 January 2021

Bevacizumab, a humanized anti-angiogenic monoclonal antibody for the treatment of colorectal cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6702983

7 January 2021

Intravitreal bevacizumab (Avastin) in the treatment of proliferative diabetic retinopathy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6702983

7 January 2021

Use of intravitreal bevacizumab as a preoperative adjunct for tractional retinal detachment repair in severe proliferative diabetic retinopathy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6702983

7 January 2021

Intravitreal injection of bevacizumab (Avastin) as adjunctive treatment of proliferative diabetic retinopathy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6702983

7 January 2021

Intravitreal bevacizumab (Avastin) therapy for persistent diffuse diabetic macular edema

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6702983

7 January 2021

Ocular complications of diabetes mellitus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6702983

7 January 2021

Vitreous levels of unbound bevacizumab and unbound vascular endothelial growth factor in two patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6702983

7 January 2021

Histological findings of a choroidal neovascular membrane removed at the time of macular translocation in a patient previously treated with intravitreal bevacizumab treatment (Avastin)

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6702983

7 January 2021